Cosmetic products are often advertised with claims that can be misleading or exaggerated.
Clinical research and medical treatment are often confused for one another, leading drug companies and healthcare professionals to risk falling out of compliance.
As more states move to decriminalize cannabis, the regulatory framework becomes more complicated. How can companies successfully navigate federal and state laws?
Drug manufacturers developing OTC drugs have a lot of important decisions to make. One of these decisions is determining which regulatory pathway works best for their product.
Drug manufacturers developing OTC drugs have a lot of important decisions to make. One of these decisions is determining which regulatory pathway works best for their product. In this episode, Darshan discusses how the OTC monograph process takes...
There is growing pressure from patients to make healthcare more transparent. However, there remain privacy concerns about publicizing clinical research data.